Snowball logo
logo
I9SA_logo

Verona Pharma plc

€90.20€0.00  (0%)
Estimate
EPS
-0.88
Beta
0.052
About the company
Ticker
I9SA
ISIN
US9250501064
Country
United Kingdom
Sector (GICS)
Healthcare
Verona Pharma plc, a biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company offers Ohtuvayre, a dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that combines bronchodilator and non-steroidal anti-inflammatory effects for the maintenance treatment of chronic obstructive pulmonary disease, as well as cystic fibrosis and asthma. Verona Pharma plc was formerly known as Isis Resources plc and changed its name to Verona Pharma plc in September 2006. The company was incorporated in 2005 and is based in London, the United Kingdom. As of October 7, 2025, Verona Pharma plc operates as a subsidiary of Merck Sharp & Dohme LLC.

Frequently asked questions

What sector does Verona Pharma plc (I9SA) operate in?

Verona Pharma plc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Verona Pharma plc (I9SA) current stock price?

As of the latest data, Verona Pharma plc stock price is €90.20, with a previous close of €90.20.

What is Verona Pharma plc (I9SA) current market capitalization?

Verona Pharma plc market cap is approximately 7.76 billion.

What is Verona Pharma plc (I9SA) Earnings Per Share (EPS)?

The trailing EPS is -€0.88.

Does Verona Pharma plc (I9SA) pay dividends?

No. Verona Pharma plc does not pay a dividend.

What is Verona Pharma plc (I9SA) beta (volatility) score?

Verona Pharma plc has a beta of 0.052, indicating lower volatility than the overall market.